Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Influenza Vaccination in RA Patients on Biologics
NCT02311855Phase 4Completed
- Sponsor
- Bassett Healthcare Network
- Start
- Aug 2014
- Primary completion
- Dec 2015
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label trial of influenza vaccine in influenza, sponsored by Bassett Healthcare Network. Primary endpoints: Initial Immune Response and Total Proportion of Seroconversion at 6 months. Started Aug 2014; status: completed.
02
Drugs
influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT02311855.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02311855.